Polypid Ltd.

Postoperative Infection Prevention

Polypid Ltd. focuses on the prevention of surgical site infection following abdominal surgery, with interest in reducing incisional infection and related postoperative complications.

  • Incisional wound infection
  • Superficial and deep surgical site infection
  • Post-abdominal surgery care

The sponsor’s clinical activity centers on anti-infective strategies used alongside standard of care in the surgical setting.

Surgical Wound Management

Its research interest extends to perioperative wound protection and the management of target incision outcomes after abdominal procedures, with emphasis on limiting infection at the surgical site.

  • Perioperative infection control
  • Wound healing support
  • Incision-related complications

Clinical work in this area reflects a therapeutic focus on maintaining post-surgical wound integrity during the recovery period.

Antimicrobial Therapeutics

Polypid Ltd. is engaged in the development of anti-infective therapy for use in the surgical environment, with attention to preventing infection rather than treating established disease.

  • Local infection prevention
  • Adjunctive antimicrobial treatment
  • Preventive infection control

This area links pharmaceutical research with practical measures for lowering infection risk after surgery.

Multinational Surgical Clinical Research

The sponsor’s trial activity spans multiple countries and research sites, supporting clinical investigation in postoperative infection prevention across diverse surgical populations.

  • Multicenter clinical research
  • International surgical studies
  • Hospital-based infection prevention

Its research footprint is concentrated in abdominal surgical care and associated infection-related outcomes.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Preventing Infections After Abdominal Surgery Using D-PLEX with Doxycycline Hyclate for Patients Undergoing Abdominal Surgery

    Not recruiting

    3 1 1
    Investigated drugs:
    Germany Hungary Ireland Italy Poland Portugal +1